These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23778174)

  • 1. Complera for the treatment of HIV.
    Belavic JM
    Nurse Pract; 2013 Jul; 38(7):8-10. PubMed ID: 23778174
    [No Abstract]   [Full Text] [Related]  

  • 2. Emtricitabine/rilpivirine/tenofovir disoproxil fumarate single-tablet regimen: a guide to its use in HIV-1 infection.
    Lyseng-Williamson KA; Scott LJ
    Clin Drug Investig; 2012 Oct; 32(10):715-22. PubMed ID: 22921088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rilpivirine and complera: new first-line treatment options.
    O'Neal R
    BETA; 2011; 23(4):14-8. PubMed ID: 22567823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rilpivirine: a step forward in tailored HIV treatment.
    Schrijvers R; Desimmie BA; Debyser Z
    Lancet; 2011 Jul; 378(9787):201-3. PubMed ID: 21763920
    [No Abstract]   [Full Text] [Related]  

  • 5. First of a kind in HIV treatment.
    FDA Consum; 2006; 40(6):34. PubMed ID: 17333565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Commission approves Atripla.
    AIDS Patient Care STDS; 2008 Jan; 22(1):87-8. PubMed ID: 18453042
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel HIV-1 treatment Stribild™ gains regulatory approval.
    Breeze S
    Expert Rev Clin Pharmacol; 2012 Nov; 5(6):613. PubMed ID: 23234321
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction.
    Francisci D; Falcinelli E; Belfiori B; Petito E; Fierro T; Baldelli F; Gresele P
    AIDS Patient Care STDS; 2011 Oct; 25(10):567-9. PubMed ID: 21851265
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiretrovirals for HIV Exposure Prophylaxis.
    Nikolopoulos G; Tsiodras S; Bonovas S; Hatzakis A
    Curr Med Chem; 2012; 19(35):5924-39. PubMed ID: 22963555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drugs.
    Pozniak A
    J HIV Ther; 2008 Jun; 13(2):27-33. PubMed ID: 18953271
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved adherence expected with new HIV combo treatment.
    Morrow T
    Manag Care; 2012 Nov; 21(11):53-4. PubMed ID: 23236718
    [No Abstract]   [Full Text] [Related]  

  • 12. Integrating HIV prevention into practice.
    Mathers BM; Cooper DA
    JAMA; 2014 Jul 23-30; 312(4):349-50. PubMed ID: 25038352
    [No Abstract]   [Full Text] [Related]  

  • 13. [Introduction. Tenofovir].
    Mallolas J
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():1. PubMed ID: 19195430
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV Pathogenesis and Treatment - Third International AIDS Society Conference.
    Susman E
    IDrugs; 2005 Oct; 8(10):813-5. PubMed ID: 16254799
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiretroviral prophylaxis for HIV prevention reaches a key milestone.
    Karim SS; Karim QA
    Lancet; 2012 Jun; 379(9831):2047-8. PubMed ID: 22608193
    [No Abstract]   [Full Text] [Related]  

  • 16. When is good good enough for HIV-1 prophylaxis?
    Buchbinder S
    Lancet Infect Dis; 2014 Nov; 14(11):1024-1025. PubMed ID: 25300861
    [No Abstract]   [Full Text] [Related]  

  • 17. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco.
    Liu A; Cohen S; Follansbee S; Cohan D; Weber S; Sachdev D; Buchbinder S
    PLoS Med; 2014 Mar; 11(3):e1001613. PubMed ID: 24595035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quadruple nucleoside therapy with zidovudine, lamivudine, abacavir and tenofovir in the treatment of HIV.
    Stürmer M; Staszewski S; Doerr HW
    Antivir Ther; 2007; 12(5):695-703. PubMed ID: 17713153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case report.
    Nguyen LB; Harent S; Peytavin G; Visseaux B; Bastard JP; Dubourg O; Lariven S; Patrick Yeni ; Yazdanpanah Y; Lescure FX
    AIDS; 2014 Aug; 28(13):1995-7. PubMed ID: 25259710
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug interactions. Super pills-the treatments of the future?
    TreatmentUpdate; 2006; 18(3):2-3. PubMed ID: 17209236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.